Demetri GD, Paz-Ares L, Farago AF, et al. Efficacy and Safety of Entrectinib in Patients with NTRK Fusion-Positive (NTRK-fp) Tumors: Pooled Analysis of STARTRK-2, STARTRK-1 and ALKA-372-001. ESMO 2018, abstract LBA17. ,Lassen UN, Albert CM, Kummar S, et al. Larotrectinib efficacy and safety in TRK fusion cancer: an expanded clinical dataset showing consistency in an age and tumor agnostic approach. ESMO 2018, abstract 409O.
“Inmiddels is echt duidelijk dat robotgeassisteerde chirurgie de route naar de toekomst is”
mei 2019 | Maag-darm-leveroncologie